Home/Filings/4/0001771961-25-000003
4//SEC Filing

Azoy Alexander 4

Accession 0001771961-25-000003

CIK 0001724521other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 7:48 PM ET

Size

5.4 KB

Accession

0001771961-25-000003

Insider Transaction Report

Form 4
Period: 2025-09-05
Azoy Alexander
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-09-05$11.88/sh1,579$18,75830,194 total
Footnotes (3)
  • [F1]Consists of 1,579 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $12.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001771961

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 7:48 PM ET
Size
5.4 KB